Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

NCT06900049 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: LE051

Sponsor

Shanghai Jiao Tong University School of Medicine